Hear from business development and investment leaders on how to be successful at landing a defining deal or partnership:
How does pharma prospect, approach and do deals?
Does your technology fit an investment thesis?
How do venture capitalists source deals and what do they look for?
Geoff Collett (Managing Director, CKC Advisory)
Geoff Collett has spent over 30 years in the pharmaceutical industry and the last 10 years at AstraZeneca in the UK. He brings $16 B worth of experience on both ‘buy side’ and ‘sell side’ of transactions including leading licensing deals, strategic collaborations, large global acquisitions and divestments.
Billy Lai (Associate, iGan Partners)
Billy works closely with the investment team and provides support in the analysis, due diligence, and sourcing of iGan investments.